Equities
  • Price (USD)273.64
  • Today's Change-19.42 / -6.63%
  • Shares traded750.98k
  • 1 Year change-60.14%
  • Beta1.7807
Data delayed at least 15 minutes, as of Aug 09 2022 21:00 BST.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

Align Technology, Inc. is a global medical device company. The Company is engaged in the design, manufacture and marketing of Invisalign clear aligners, iTero intraoral scanners and services for dentistry, and exocad computer-aided design and computer-aided manufacturing (CAD/CAM) software for dental laboratories and dental practitioners. It operates through two segments: Clear Aligner, and Systems and Services. Its Clear Aligner segment consists of Comprehensive Products, which includes Invisalign Comprehensive and Invisalign First; Non-Comprehensive Products, which includes Invisalign Moderate, Lite and Express packages and Invisalign Go and Invisalign Go Plus, and Non-Case products, which include retention products, Invisalign training, adjusting tools used by dental professionals during the course of treatment and consumer products that are complementary to its doctor-prescribed principal products. Its Systems and Services segment consists of its iTero intraoral scanning systems.

  • Revenue in USD (TTM)3.99bn
  • Net income in USD619.03m
  • Incorporated1997
  • Employees22.54k
  • Location
    Align Technology Inc410 North Scottsdale Road, Suite 1300TEMPE 85281United StatesUSA
  • Phone+1 (408) 738-1500
  • Fax+1 (408) 470-1010
  • Websitehttps://www.aligntech.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Teleflex Incorporated2.81bn509.89m11.69bn14.00k23.183.0415.764.1610.7510.7559.2482.140.40712.536.77200,601.607.395.578.056.1054.9355.2218.1613.901.4312.190.308117.9710.748.5144.4715.396.150.00
ABIOMED, Inc.1.06bn217.58m12.81bn2.00k59.468.3652.1912.124.744.7423.0033.710.66812.1911.75527,367.4013.7616.9114.9618.7581.4882.1320.6023.456.86--0.000.0021.7418.30-39.4721.24-6.64--
Cooper Companies Inc3.14bn948.00m16.07bn12.00k17.122.2912.555.1219.0219.0262.95142.260.3021.816.14261,625.009.1214.0910.4515.9965.9065.0330.2034.480.6882--0.31680.338620.228.241,135.1960.807.030.00
Hologic, Inc.5.23bn1.51bn17.83bn6.71k12.033.569.133.415.945.9420.5420.030.58243.526.35779,433.3016.858.3319.5310.1763.5358.3528.9316.163.3235.740.36270.0049.1414.7467.8241.4210.56--
Insulet Corporation1.18bn34.60m17.95bn2.30k542.9242.49188.7815.240.47650.476516.746.090.58361.457.68512,217.401.710.19891.950.225568.0765.322.940.31743.542.480.76970.0021.4924.52147.06--40.87--
Steris PLC4.77bn376.96m20.90bn16.42k55.863.2621.244.383.743.7447.3764.020.40994.396.33290,654.803.225.333.545.8444.1643.087.8710.081.358.180.318339.1147.5511.90-38.6317.2710.719.17
Align Technology, Inc.3.99bn619.03m21.37bn22.54k35.065.9329.035.367.817.8150.3646.110.71214.474.59177,008.7011.0525.1216.0736.5072.6073.4015.5230.361.15--0.000.0059.9029.63-56.5332.4141.55--
Zimmer Biomet Holdings Inc7.41bn299.60m23.60bn19.50k79.151.9518.173.191.421.0935.2857.820.32430.96835.48379,841.001.321.031.491.1669.5771.164.063.310.94997.030.331977.3511.560.4339400.007.13-1.880.00
West Pharmaceutical Services Inc.2.93bn685.60m24.40bn10.07k36.6810.0630.868.338.988.9838.3332.760.93044.585.81290,968.7021.1714.1125.3516.7840.8735.6122.7516.012.41128.800.094213.6131.8913.4190.7635.688.297.09
Baxter International Inc14.19bn1.01bn29.69bn60.00k29.533.3513.452.092.002.0027.9917.580.5513.656.32236,550.003.976.034.637.2239.1641.587.2010.021.338.000.652138.319.524.7016.52-23.700.658916.53
Data as of Aug 09 2022. Currency figures normalised to Align Technology Inc's reporting currency: US Dollar USD

Institutional shareholders

38.83%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 31 Mar 20225.64m7.16%
Edgewood Management LLCas of 31 Mar 20224.37m5.55%
BlackRock Fund Advisorsas of 31 Mar 20223.60m4.57%
SSgA Funds Management, Inc.as of 31 Mar 20223.08m3.91%
Janus Henderson Investors US LLCas of 31 Mar 20222.89m3.66%
T. Rowe Price Associates, Inc. (Investment Management)as of 31 Mar 20222.51m3.19%
AllianceBernstein LPas of 31 Mar 20222.47m3.13%
Sands Capital Management LLCas of 31 Mar 20222.36m3.00%
Polen Capital Management LLCas of 31 Mar 20221.87m2.38%
Wellington Management Co. LLPas of 31 Mar 20221.80m2.28%
More ▼
Data from 31 Mar 2022 - 31 Mar 2022Source: FactSet Research Systems Inc.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.